Related Stories
Business & Markets
TUSPAN syrup is the newest addition to our OTC portfolio based on extract of ivy leaf.
Progress
Strongly committed with local communities and people wellness, we have been integrating...
Sopharma's capabilities include the development of medicinal products of various pharmaceutical forms - solid (capsules and tablets), liquids (solutions, suspensions), semi-solid (creams, ointments, gels, suppositories) and dosage forms for parenteral administration (solutions for injection/infusion, powders for solutions for injection/infusion) as well as medical cosmetics.
Our core strength lies is developing generics. We have the capability to develop the products within established timelines and without compromising on quality.
We have around 60 research scientists working in R&D center. Our scientists have expertise in developing technology for pharmaceutical products, Active Pharmaceutical Ingredients (APIs) and analytical development.